The so-called “weekend effect”—that idea that patients admitted to the hospital on Saturdays, Sundays and holidays face greater odds of readmission down the line—doesn’t apply to victims of cardiac arrest, according to data presented at the British Cardiovascular Society Conference in Manchester June 2.

Loneliness, above all else, was an independent predictor of whether patients stuck to their doctors’ guidelines.

Consuming 32 ounces or more of an energy drink within an hour could raise blood pressure and trigger life-threatening arrhythmias, according to research published ahead of print in the Journal of the American Heart Association.

Almost half of U.S. citizens with hypertension are unworried about future CV events like heart attack and stroke, according to a recent survey conducted for the American Medical Association and American Heart Association.

People who take popular heartburn drugs like Prevacid, Prilosec and Nexium are vulnerable to death from cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer, according to new research published in The BMJ.

The U.S. FDA on May 29 granted Amarin’s Vascepa (icosapent ethyl) priority review for a supplemental indication that would state the medication reduces cardiovascular risk in addition to helping patients manage elevated triglyceride levels.

A population-based cohort study out of France has identified a link between the consumption of ultra-processed foods and CVD, with a higher intake of sweet and starchy snacks translating to increased risks for cardiovascular, coronary heart and cerebrovascular diseases.

It’s unnecessary to fast before a complete cholesterol test, according to new research, especially if the sole intention of that test is to determine a patient’s risk of future cardiovascular events.